Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Sep 22;79(19):1645-1651.
doi: 10.1093/ajhp/zxac175.

Impact of pharmacist participation in the patient care team on value-based health measures

Affiliations
Observational Study

Impact of pharmacist participation in the patient care team on value-based health measures

Michael Patti et al. Am J Health Syst Pharm. .

Abstract

Purpose: To evaluate whether pharmacist engagement on the interdisciplinary team leads to improved performance on diabetes-related quality measures.

Methods: This was a retrospective observational study of patients seen in primary care and specialty clinics from October 2014 to October 2020. Patients were included if they had a visit with a physician, nurse practitioner, physician's assistant, or clinical pharmacist practitioner (CPP) within the study period and had a diagnosis of diabetes. The intervention group included patients with at least one visit with a CPP, while the control group consisted of patients who were exclusively managed by non-CPP providers. The primary outcome of this study was the median change in glycosylated hemoglobin (HbA1c) from baseline to follow-up at 3, 6, and 12 months. The secondary outcome was the probability of achieving the HbA1c targets of <7% and <8% at 3, 6, and 12 months.

Results: Patients referred to a CPP had higher HbA1c levels at baseline and were more likely to have concomitant hypertension (P < 0.01). Patients seen by a CPP had 0.31%, 0.41%, and 0.44% greater reductions in HbA1c compared to patients in the control group at 3, 6, and 12 months, respectively (P < 0.01). Patients managed by a CPP were also more likely to achieve the identified HbA1c targets of <7% and <8%.

Conclusion: Patients referred to a CPP were more complex, but had greater reductions in HbA1c and were more likely to achieve HbA1c goals included in the organization's quality measures. This study demonstrates the value of pharmacists in improving patient care and their role in supporting an organization's achievement of value-based quality measures.

Keywords: collaborative practice; diabetes; hypertension; patient care; pharmacist; quality of health care.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Subject disposition flow chart. A1c indicates glycosylated hemoglobin; CKDS, chronic kidney disease; CPP, clinical pharmacy practitioner; DM, diabetes melitus; ESRD, end-stage renal disease.

References

    1. Patient Protection and Affordable Care Act, Pub L No. 111-148, 124 Stat 119 (2010).
    1. AMCP Partnership Forum: advancing value-based contracting. J Manag Care Spec Pharm. 2017;23(11):1096-1102. - PMC - PubMed
    1. National Committee for Quality Insurance. HEDIS and performance measurement. Accessed May 26, 2021. https://www.ncqa.org/hedis/
    1. Ravn-Nielsen LV, Duckert ML, Lund ML, et al. . Effect of an in-hospital multifaceted clinical pharmacist intervention on the risk of readmission: a randomized clinical trial. JAMA Intern Med. 2018;178(3):375-382. - PMC - PubMed
    1. Arnold ME, Buys L, Fullas F. Impact of pharmacist intervention in conjunction with outpatient physician follow-up visits after hospital discharge on readmission rate. Am J Health-Syst Pharm. 2015;72(11 suppl 1):S36-S42. - PubMed

Publication types

Substances

Grants and funding